Literature DB >> 19384871

Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population.

Eirik A Torheim1, Lishomwa C Ndhlovu, Frank O Pettersen, Trine-Lise Larsen, Aashish R Jha, Knut M Torgersen, Dag Kvale, Douglas F Nixon, Kjetil Taskén, Einar M Aandahl.   

Abstract

Recent studies have indicated that Treg contribute to the HIV type 1 (HIV-1)-related immune pathogenesis. However, it is not clear whether T cells with suppressive properties reside within the HIV-1-specific T-cell population. Here, PBMC from HIV-1-infected individuals were stimulated with a 15-mer Gag peptide pool, and HIV-1-specific T cells were enriched by virtue of their secretion of IL-10 or IFN-gamma using immunomagnetic cell-sorting. Neither the IL-10-secreting cells nor the IFN-gamma-secreting cells expressed the Treg marker FOXP3, yet the IL-10-secreting cells potently suppressed anti-CD3/CD28-induced CD4(+) as well as CD8(+) T-cell proliferative responses. As shown by intracellular cytokine staining, IL-10- and IFN-gamma-producing T cells represent distinct subsets of the HIV-1-specific T cells. Our data collectively suggest that functionally defined HIV-1-specific T-cell subsets harbor potent immunoregulatory properties that may contribute to HIV-1-associated T-cell dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384871      PMCID: PMC2742768          DOI: 10.1002/eji.200839002

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

1.  Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection.

Authors:  L K Musey; J N Krieger; J P Hughes; T W Schacker; L Corey; M J McElrath
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

2.  Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages.

Authors:  F Ameglio; P Cordiali Fei; M Solmone; C Bonifati; G Prignano; A Giglio; F Caprilli; G Gentili; M R Capobianchi
Journal:  J Biol Regul Homeost Agents       Date:  1994 Apr-Jun       Impact factor: 1.711

3.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Authors:  E S Rosenberg; J M Billingsley; A M Caliendo; S L Boswell; P E Sax; S A Kalams; B D Walker
Journal:  Science       Date:  1997-11-21       Impact factor: 47.728

4.  T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects.

Authors:  M T Roos; F Miedema; M Koot; M Tersmette; W P Schaasberg; R A Coutinho; P T Schellekens
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

5.  Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin.

Authors:  M Clerici; A Sarin; J A Berzofsky; A L Landay; H A Kessler; F Hashemi; C W Hendrix; S P Blatt; J Rusnak; M J Dolan; R L Coffman; P A Henkart; G M Shearer
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

6.  Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients.

Authors:  E M Aandahl; P Aukrust; B S Skålhegg; F Müller; S S Frøland; V Hansson; K Taskén
Journal:  FASEB J       Date:  1998-07       Impact factor: 5.191

7.  In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus.

Authors:  M J Dolan; M Clerici; S P Blatt; C W Hendrix; G P Melcher; R N Boswell; T M Freeman; W Ward; R Hensley; G M Shearer
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

Review 8.  The natural history and pathogenesis of HIV infection.

Authors:  H W Sheppard; M S Ascher
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

9.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Authors:  M Clerici; T A Wynn; J A Berzofsky; S P Blatt; C W Hendrix; A Sher; R L Coffman; G M Shearer
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

View more
  8 in total

Review 1.  Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states.

Authors:  Kristoffer Watten Brudvik; Kjetil Taskén
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.

Authors:  Frank O Pettersen; Eirik A Torheim; Anders E A Dahm; Ingeborg S Aaberge; Andreas Lind; Malin Holm; Einar M Aandahl; Per M Sandset; Kjetil Taskén; Dag Kvale
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 3.  Creating order from chaos: cellular regulation by kinase anchoring.

Authors:  John D Scott; Carmen W Dessauer; Kjetil Taskén
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-08       Impact factor: 13.820

4.  HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.

Authors:  Benoît Vingert; Daniela Benati; Olivier Lambotte; Pierre de Truchis; Laurence Slama; Patricia Jeannin; Moran Galperin; Santiago Perez-Patrigeon; Faroudy Boufassa; William W Kwok; Fabrice Lemaître; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

Review 5.  Networking at the level of host immunity: immune cell interactions during persistent viral infections.

Authors:  Cherie T Ng; Laura M Snell; David G Brooks; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

Review 6.  HIV-1 neuroimmunity in the era of antiretroviral therapy.

Authors:  Stephanie D Kraft-Terry; Andrew R Stothert; Shilpa Buch; Howard E Gendelman
Journal:  Neurobiol Dis       Date:  2010-01-04       Impact factor: 5.996

Review 7.  CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution.

Authors:  Andrea De Maria; Andrea Cossarizza
Journal:  J Transl Med       Date:  2011-06-16       Impact factor: 5.531

8.  The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.

Authors:  Kristian Tonby; Ida Wergeland; Nora V Lieske; Dag Kvale; Kjetil Tasken; Anne M Dyrhol-Riise
Journal:  BMC Infect Dis       Date:  2016-10-24       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.